Skip to main content
. 2021 Nov 5;8(11):ofab540. doi: 10.1093/ofid/ofab540

Table 1.

Demographic Variables

AMA (n=26) Non-AMA (n=20) Treatment Complete (n=83) P Value
Female 3 (12)a,b 0 (0)b 22 (27)a .01
Race/ethnicity .22
 White non-Hispanic 12 (46) 12 (60) 27 (33)
 Hispanic 10 (39) 6 (30) 41 (49)
 Black non-Hispanic 4 (15) 2 (10) 15 (18)
Age, y 41 ± 12 43 ± 8 45 ± 10 .15
Drug of choice
 Cocaine 7 (27)a 8 (40)a,b 45 (54)b .04
 Heroin 9 (35) 3 (15) 26 (31) .29
 Methamphetamines 14 (54) 10 (50) 41 (49) .46
 Phencyclidine 2 (8) 1 (5) 1 (1) .22
 Prescription drugs 1 (4) 2 (10) 1 (1) .12
Discharge diagnosis
 Endocarditis 7 (27) 1 (5) 8 (10) .05
 Bacteremia 6 (23) 6 (30) 31 (37) .38
 Bone and joint 13 (50) 10 (50) 35 (42) .69
 Skin and soft tissue 0 (0) 0 (0) 4 (5) .32
 Diabetic foot infection 5 (19) 4 (20) 14 (17) .93
 Pulmonary 0 (0) 2 (10) 5 (6) .31
 GI/GU 0 (0) 0 (0) 2 (2) .57
 CNS/ENT 0 (0) 2 (10) 4 (5) .28
Antibiotic at discharge
 Cephalosporin 16 (62) 8 (40) 48 (58) .29
 Vancomycin 0 (0) 10 (50) 23 (28) .16
 Carbapenem 0 (0) 1 (5) 7 (8) .29
 Penicillin 2 (8) 4 (20) 12 (15) .48
 Daptomycin 0 (0) 0 (0) 1 (1) .76
Duration of planned antibiotic treatment, d 31 (22–34) 32 (18–35) 28 (15–33) .36
Duration of actual antibiotic treatment, d 3 (2–11) 21 (9–31) 28 (20–35) <.01

Table 1 demonstrates demographic and clinical variables including drug of choice, final diagnosis, and details regarding antibiotic treatment and duration among people who use drugs discharged to short-term nursing facilities for extended courses of intravenous antibiotics (n=129). Data are presented as No. (%), median (IQR), or mean ± SD.

Abbreviations: AMA, against medical advice; CNS/ENT, Central Nervous System/Ear Nose and Throat; GI/GU, Gastroenterology/Genitourinary; IQR, interquartile range.